Management of Resistant Jock Itch Extending to Buttocks
Complete the current course of pulse dose itraconazole and add a topical antifungal cream to the affected areas, including the buttocks, for at least 2-4 weeks after all lesions have resolved.
Assessment of Current Situation
The patient presents with:
- Jock itch rash extending into buttocks
- Daily noticeable enlargement despite treatment
- Improved itching symptoms
- Currently on day 7 of pulse dose itraconazole
- Previous treatment failures:
- OTC antifungal creams
- 14-day course of oral terbinafine
- 10-day course of oral fluconazole
Treatment Approach
1. Complete Current Therapy
- Continue the current pulse dose itraconazole regimen to completion
- Itraconazole is effective against both dermatophytes and Candida species, making it appropriate for resistant fungal infections 1
- Pulse therapy with itraconazole (typically 200mg twice daily for 1 week per month) has shown clinical response rates of 90% and mycological cure rates of 76-77% for dermatomycoses 2
2. Add Adjunctive Topical Therapy
- Add a prescription-strength topical antifungal to use concurrently:
- Ciclopirox 8% cream applied twice daily
- OR Econazole 1% cream applied twice daily
- Apply to all affected areas including the buttocks and surrounding skin
3. Extend Treatment Duration
- Continue treatment for 2-4 weeks after all visible lesions have resolved 1
- For resistant infections, treatment duration may need to be longer than standard courses
Rationale for This Approach
Superiority of itraconazole for resistant infections:
Benefit of combination therapy:
- Adding topical therapy to systemic treatment addresses both the systemic spread and provides direct local antifungal action
- This dual approach is particularly important when the infection is expanding despite systemic therapy
Importance of adequate treatment duration:
- The British Association of Dermatologists guidelines recommend continuing treatment for 2-4 weeks after clinical resolution to ensure mycological cure 1
Monitoring and Follow-up
- Evaluate the response after completing the current pulse of itraconazole
- If improvement is noted but complete resolution has not occurred, consider:
- An additional pulse of itraconazole (200mg twice daily for 1 week) 2
- Extending the topical treatment duration
Common Pitfalls to Avoid
Premature discontinuation:
- Stopping treatment when symptoms improve but before complete resolution often leads to recurrence
- Continue treatment for 2-4 weeks after visible clearing of the rash
Inadequate application area:
- Apply topical treatments beyond the visible borders of the rash (approximately 2cm)
- Include all potentially affected areas, including skin folds and adjacent regions
Overlooking contributing factors:
- Ensure the patient:
- Wears loose-fitting, breathable cotton underwear
- Thoroughly dries the affected areas after bathing
- Changes clothes, particularly underwear, daily
- Avoids sharing towels or personal items
- Ensure the patient:
Misdiagnosis:
- If no improvement occurs after completing the recommended treatment, consider:
- Skin biopsy to confirm diagnosis
- Fungal culture with susceptibility testing
- Alternative diagnoses such as psoriasis, seborrheic dermatitis, or contact dermatitis
- If no improvement occurs after completing the recommended treatment, consider:
If the infection continues to spread or fails to improve after completing the current pulse of itraconazole plus topical therapy, referral to a dermatologist for further evaluation and possibly different systemic therapy options would be warranted.